Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia

Details for Australian Patent Application No. 2001253233 (hide)

Owner Kos Pharmaceuticals, Inc. Trustees of Boston University

Inventors Zannis, Vassilis I.; Kypreos, Kyriakos E.

Agent Griffith Hack

Pub. Number AU-B-2001253233

PCT Pub. Number WO01/77136

Priority 09544386 06.04.00 US; 09827854 05.04.01 US; 09679088 04.10.00 US

Filing date 6 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 7 December 2006

International Classifications

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

7 December 2006 Application Accepted

  Published as AU-B-2001253233

5 April 2007 Standard Patent Sealed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253234

2001253232-Systems and methods for recognizing preferred wagerers